Updated December 1 at 12:28am
Health Care
277 results total, viewing 1 - 10
HealthSource RI said 31,012 individuals are enrolled in 2016 health insurance coverage as of Nov. 21, paid and unpaid, and that nearly all of them are current HSRI enrollees that were auto-renewed. more
The Champlin Foundations has awarded the Community College of Rhode Island $324,180 to establish a high-fidelity allied simulation center at the college’s Flanagan Campus in Lincoln. more
Twenty-six Real Jobs RI grant recipients were announced Monday by Gov. Gina M. Raimondo and the congressional delegation. more
CVS Health Corp.’s drug-benefits unit will cover Amgen Inc.’s new cholesterol-cutting injections while excluding a competing treatment from Sanofi and Regeneron Pharmaceuticals Inc., pushing for savings from medications that list for more than $14,000 a year. more
High levels of satisfaction have been found among Rhode Islanders who took advantage of the state’s new temporary caregiver insurance to take care of a new child or an elderly or ill family member, according to University of Rhode Island researchers. more
Two Rhode Island companies received perfect scores of 100 percent on the 2016 Corporate Equality Index: Blue Cross & Blue Shield of Rhode Island and CVS Health Corp. more
(Updated 3:50 and 4:49 p.m.) ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people. more
Bradley Hospital and Women & Infants Hospital of Rhode Island have been recognized as top performers on key quality measures for 2014 by The Joint Commission, an accreditor of health organizations in the United States. more
Blue Cross & Blue Shield of Rhode Island will lay off approximately 80 employees as a result of a new strategic relationship with technology company Dell. more
The U.K.’s health-cost regulator turned down Amgen Inc.’s new cholesterol medicine Repatha in a preliminary ruling, saying the drugmaker may have over-estimated the risk of heart disease that results from people having too much cholesterol. more
1 | 2 | 3 | 4 | 5 | 6 | 7 28 | Next »